AstraZeneca’s COVID vaccine may cause blood clotting: Should you be worried?

In court documents, AstraZeneca, a British pharmaceutical company, has acknowledged for the first time that its COVID-19 vaccine may cause TTS, a rare side effect linked to blood clotting.

Low blood platelet counts and blood clots are symptoms of TTS, also known as thrombosis with thrombocytopenia syndrome.

Due to allegations that their vaccination caused fatalities and significant injuries in numerous cases, the business is facing up to 51 lawsuits, including class action lawsuits.

Millions of individuals throughout the world, particularly those in India, have been impacted by this revelation. In that country, the Covishield vaccine was used to prevent serious Covid-19 problems.

Should you be Worried ?

Doctors were questioned by India Today over AstraZeneca’s admission and the unusual side effect that the company’s COVID-19 vaccine caused.

“The side effects associated with vaccination often manifest 1-6 weeks following injection. Thus, those in India who received the vaccination two years ago don’t need to be concerned,” stated Dr. Sudhir Kumar, a neurologist at Apollo Hospital in Hyderabad.

This specific result is only reported in the first month after the first dose, not later, stated Dr. Rajeev Jayadevan, Co-Chairman of the National Indian Medical Association.

The incidence of TTS following vaccination is unknown in India, according to Dr. Kumar.

There have only been few case reports published. In light of the fact that millions of vaccine doses have been given, TTP is incredibly uncommon following Covid inoculation, the specialist stated.

Millions of patients throughout the world have been impacted by AstraZeneca’s admission, including those in India, where the vaccine—marketed as Covishield—was given to lower the risk of serious Covid-19 problems. (Image: Getty Pictures)

The expert stated that these discoveries are not new. Since 2021, there have really been rare case reports of TTS from all around the world following the COVID-19 vaccines.

Since Eli Moschcowitz reported the first instance of TTS in 1924, involving a 16-year-old girl, the disease has gained widespread recognition and awareness during the past century. For the past forty years, medical curriculum have included the fundamental mechanisms of TTP, which have been understood since 1982, according to Dr. Kumar.

While COVID vaccines do increase the risk of blood clots, the risk is very small.

“This has been proven in numerous scientific studies published in India and other countries,” Dr. Kumar stated. For the record, COVID infection raises the risk of blood clot development far more than COVID vaccination does.”

Dr. Jayadevan went on to say that vaccination lowers the risk of clots, heart attacks, and strokes, all of which are known to be caused by COVID-19 alone.

Is Covaxin Better than Covishield?

Dr. Kumar said that there’s not enough data to help us choose one COVID vaccine over another, based on the risk of adverse effects.

“Moreover, TTS has been reported with other vaccines as well, such as influenza vaccine, pneumococcal vaccine, H1N1 vaccination, and rabies vaccine,” Dr. Kumar stated.

Experts state that persons who receive the COVID-19 vaccination have a decreased risk of developing clots, heart attacks, and strokes, which are known side effects of the virus.

Dr. Jayadevan added that both vaccines are effective.

Nothing indicates that one is superior to the other. Every medical procedure, including vaccinations, has negative effects. He remarked, “Cronies of people in India who received these immunizations are today living and well.

What are the Side Effects?

A few uncommon side effects of adenovirus vaccines, such as Bell’s palsy (facial weakness), stroke, cerebral venous sinus thrombosis, and heart attacks, are linked to conditions like Guillain Barre syndrome, which results in paralysis of the limbs and legs.

Following the uncommon side effect of blood clotting, the AstraZeneca vaccine was discontinued in a number of nations.